Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Point and Frameshift Mutations

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.

Circulation·2026

Same author

Image-based, pooled phenotyping reveals multidimensional, disease-specific variant effects.

Cell·2026

Same author

Global genetic interaction network of a human cell maps conserved principles and informs functional interpretation of gene co-essentiality profiles.

Cell·2026

Same author

Experimental assessment of AI-based interactome mapping.

Nature communications·2026

Same author

A scalable approach to resolving variants of uncertain significance.

bioRxiv : the preprint server for biology·2026

Same author

Mapping the Functional Landscape of <i>KCNQ1</i> to Define Ion Channel Mechanisms and Arrhythmia Risk.

medRxiv : the preprint server for health sciences·2025

Search research articles

Related Experiment Video

Updated: Oct 19, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Improved pathogenicity prediction for rare human missense variants.

Yingzhou Wu¹, Roujia Li¹, Song Sun¹

¹The Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 3E1, Canada; Department of Computer Science, University of Toronto, Toronto, ON M5S 2E4, Canada; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON M5G 1X5, Canada.

American Journal of Human Genetics

|September 22, 2021

Summary

VARITY is a new computational tool that improves the prediction of pathogenic human variants. It identifies more disease-causing missense variations than previous methods, advancing personalized genomic medicine.

Keywords:

balanced precision disease variants human genetics machine learning missense variants predictive medicine rare variants variant pathogenicity

More Related Videos

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Related Experiment Videos

Last Updated: Oct 19, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Area of Science:

Genomics
Computational Biology
Medical Genetics

Background:

Personalized genomic medicine relies on accurate assessment of rare human variant pathogenicity.
Missense variations pose significant challenges for computational prediction due to data quality and bias issues.

Purpose of the Study:

To develop a novel computational method, VARITY, for improved pathogenicity assessment of human variants.
To address challenges in training data quantity, quality, and bias in variant pathogenicity prediction.

Main Methods:

VARITY utilizes a larger set of training examples with varying degrees of accuracy and representativity.
The method excludes features derived from variant annotation and protein identity to mitigate circularity and bias.
Feature contributions to pathogenicity predictions are quantified to provide interpretability.

Main Results:

VARITY demonstrated superior performance compared to existing computational methods.
The tool identified at least 10% more pathogenic variants at a high stringency threshold (90% precision).

Conclusions:

VARITY offers a more accurate and robust approach to predicting variant pathogenicity.
This advancement supports the clinical utility of personalized genomic medicine by improving variant interpretation.